Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 70% ± 14% | |
GABAergic neuron | 9 studies | 46% ± 22% | |
classical monocyte | 7 studies | 20% ± 3% | |
endothelial cell | 7 studies | 36% ± 17% | |
neuron | 6 studies | 38% ± 18% | |
interneuron | 6 studies | 43% ± 16% | |
retinal ganglion cell | 6 studies | 66% ± 32% | |
microglial cell | 5 studies | 36% ± 22% | |
basal cell | 5 studies | 33% ± 21% | |
type I pneumocyte | 5 studies | 41% ± 7% | |
astrocyte | 5 studies | 32% ± 27% | |
cholangiocyte | 4 studies | 44% ± 22% | |
hepatocyte | 4 studies | 54% ± 30% | |
granule cell | 4 studies | 57% ± 9% | |
retina horizontal cell | 4 studies | 89% ± 12% | |
retinal cone cell | 4 studies | 70% ± 20% | |
GABAergic interneuron | 3 studies | 39% ± 16% | |
epithelial cell | 3 studies | 17% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 19% ± 1% | |
GABAergic amacrine cell | 3 studies | 56% ± 6% | |
OFF-bipolar cell | 3 studies | 88% ± 5% | |
ON-bipolar cell | 3 studies | 70% ± 7% | |
amacrine cell | 3 studies | 35% ± 12% | |
retinal rod cell | 3 studies | 53% ± 32% | |
oligodendrocyte | 3 studies | 40% ± 29% | |
myoepithelial cell | 3 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 545.07 | 89 / 89 | 70% | 2.66 | 630 / 901 |
thymus | 99% | 1144.25 | 647 / 653 | 55% | 1.83 | 332 / 605 |
lung | 98% | 504.49 | 567 / 578 | 39% | 1.62 | 453 / 1155 |
liver | 88% | 656.62 | 200 / 226 | 24% | 0.67 | 98 / 406 |
esophagus | 42% | 137.12 | 602 / 1445 | 69% | 5.01 | 127 / 183 |
prostate | 95% | 469.60 | 232 / 245 | 12% | 0.18 | 58 / 502 |
skin | 98% | 832.25 | 1766 / 1809 | 6% | 0.16 | 30 / 472 |
brain | 75% | 313.52 | 1993 / 2642 | 21% | 0.49 | 147 / 705 |
adrenal gland | 38% | 80.53 | 99 / 258 | 55% | 2.49 | 126 / 230 |
breast | 61% | 842.05 | 281 / 459 | 29% | 0.89 | 319 / 1118 |
intestine | 73% | 343.00 | 701 / 966 | 15% | 0.30 | 78 / 527 |
bladder | 62% | 532.19 | 13 / 21 | 22% | 1.32 | 110 / 504 |
ovary | 68% | 182.16 | 122 / 180 | 12% | 0.32 | 50 / 430 |
spleen | 75% | 136.22 | 180 / 241 | 0% | 0 | 0 / 0 |
uterus | 37% | 256.12 | 63 / 170 | 33% | 1.23 | 151 / 459 |
tonsil | 0% | 0 | 0 / 0 | 69% | 3.12 | 31 / 45 |
stomach | 47% | 157.91 | 168 / 359 | 21% | 0.63 | 59 / 286 |
peripheral blood | 53% | 165.12 | 489 / 929 | 0% | 0 | 0 / 0 |
heart | 42% | 126.00 | 358 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 34% | 88.94 | 448 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 2% | 2.89 | 8 / 328 | 8% | 0.27 | 15 / 178 |
adipose | 6% | 11.39 | 75 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
muscle | 0% | 0.13 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030879 | Biological process | mammary gland development |
GO_0038133 | Biological process | ERBB2-ERBB3 signaling pathway |
GO_0032148 | Biological process | activation of protein kinase B activity |
GO_0007171 | Biological process | activation of transmembrane receptor protein tyrosine kinase activity |
GO_0055007 | Biological process | cardiac muscle cell differentiation |
GO_0038127 | Biological process | ERBB signaling pathway |
GO_0014032 | Biological process | neural crest cell development |
GO_0048513 | Biological process | animal organ development |
GO_0050919 | Biological process | negative chemotaxis |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0042060 | Biological process | wound healing |
GO_0060956 | Biological process | endocardial cell differentiation |
GO_0038138 | Biological process | ERBB4-ERBB4 signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_0060379 | Biological process | cardiac muscle cell myoblast differentiation |
GO_0099149 | Biological process | regulation of postsynaptic neurotransmitter receptor internalization |
GO_0007154 | Biological process | cell communication |
GO_0051155 | Biological process | positive regulation of striated muscle cell differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0051048 | Biological process | negative regulation of secretion |
GO_0038135 | Biological process | ERBB2-ERBB4 signaling pathway |
GO_0003222 | Biological process | ventricular trabecula myocardium morphogenesis |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0038129 | Biological process | ERBB3 signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0007399 | Biological process | nervous system development |
GO_0038130 | Biological process | ERBB4 signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0005178 | Molecular function | integrin binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0030296 | Molecular function | protein tyrosine kinase activator activity |
GO_0043125 | Molecular function | ErbB-3 class receptor binding |
GO_0045499 | Molecular function | chemorepellent activity |
GO_0030297 | Molecular function | transmembrane receptor protein tyrosine kinase activator activity |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | NRG1 |
Protein name | Pro-neuregulin-1, membrane-bound isoform (Pro-NRG1) [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)] Neuregulin 1 Neuregulin 1 isoform HRG-beta3 (Neuregulin 1, isoform CRA_g) NRG1 protein Neuregulin 1 variant fetal a IV 1 Neuregulin 1 isoform HRG-gamma Neuregulin 1 variant fetal b IV-beta 1a Neuregulin 1 variant fetal c IV 2 Heregulin-gamma protein isoform 2 Heregulin-gamma protein isoform 1 Neuregulin 1 isoform 4 Heregulin-beta 3 protein isoform Neuregulin 1 isoform HRG-gamma (Neuregulin 1, isoform CRA_l) Neuregulin 1 type IV beta 3 Neuregulin 1 isoform HRG-alpha (Neuregulin 1 isoform HRG-beta1) (Neuregulin 1 isoform HRG-beta2) (Neuregulin 1 isoform HRG-beta3) (Neuregulin 1 isoform HRG-gamma) (Neuregulin 1 isoform ndf43) Pro-neuregulin-1, membrane-bound isoform |
Synonyms | GGF hCG_14780 HRGA HGL NDF SMDF |
Description | FUNCTION: Direct ligand for ERBB3 and ERBB4 tyrosine kinase receptors. Concomitantly recruits ERBB1 and ERBB2 coreceptors, resulting in ligand-stimulated tyrosine phosphorylation and activation of the ERBB receptors. The multiple isoforms perform diverse functions such as inducing growth and differentiation of epithelial, glial, neuronal, and skeletal muscle cells; inducing expression of acetylcholine receptor in synaptic vesicles during the formation of the neuromuscular junction; stimulating lobuloalveolar budding and milk production in the mammary gland and inducing differentiation of mammary tumor cells; stimulating Schwann cell proliferation; implication in the development of the myocardium such as trabeculation of the developing heart. Isoform 10 may play a role in motor and sensory neuron development. Binds to ERBB4 . Binds to ERBB3 . Acts as a ligand for integrins and binds (via EGF domain) to integrins ITGAV:ITGB3 or ITGA6:ITGB4. Its binding to integrins and subsequent ternary complex formation with integrins and ERRB3 are essential for NRG1-ERBB signaling. Induces the phosphorylation and activation of MAPK3/ERK1, MAPK1/ERK2 and AKT1 . Ligand-dependent ERBB4 endocytosis is essential for the NRG1-mediated activation of these kinases in neurons (By similarity). . |
Accessions | A0A494C054 Q86WJ0 ENST00000523041.2 H0YDC2 B9EK51 B0FYA8 ENST00000287842.7 [Q02297-6] A5YAK7 A0A494C043 Q7RTW4 A0A494C0T5 Q7RTW5 A6MW56 ENST00000520407.5 [Q02297-9] H0YBA3 ENST00000652588.1 ENST00000652698.1 E3SFN0 H0YCP0 ENST00000522402.6 B0FYA9 A0A494C0K4 ENST00000652592.1 ENST00000405005.8 [Q02297-1] ENST00000650819.1 A0A494C0L9 A0A494C1F5 ENST00000518084.5 B5BU95 A0A494C1F8 A0A494C0Q4 ENST00000522569.1 ENST00000519301.6 [Q02297-11] Q7RTW3 A6MW54 ENST00000521670.5 [Q02297-3] ENST00000651149.1 Q02297 ENST00000356819.7 [Q02297-7] A0A5F9ZHA5 A0A494C114 ENST00000651333.2 ENST00000650866.1 Q96IB3 ENST00000523534.5 A0A024QY88 E5RIG8 ENST00000651335.1 ENST00000523079.5 [Q02297-12] A5YAK8 A0A494C1B5 A0A494BZT4 B0FYA7 B0FWZ3 E5RHP6 B7Z168 E3SFM9 ENST00000520502.7 [Q02297-10] ENST00000519240.5 Q6ICV5 ENST00000650980.1 Q7RTV8 ENST00000650856.1 E5RHQ1 A0A494C1G2 ENST00000518206.5 A6MW55 ENST00000650919.1 [Q02297-8] Q6PK61 ENST00000650967.1 A5YAK6 ENST00000651696.1 |